In may, the GPvP Inspectorate held their symposium, which provided a platform for information sharing and discussion between inspectors and assessors from the MHRA and industry colleagues working within pharmacovigilance and associated departments.
Senior GCP Inspector & GPvP Inspectorate Operations Manager, IE&S
Medicines and Healthcare products Regulatory Agency (MHRA)
Mandeep initially joined the MHRA as a Good Clinical Practice (GCP) Inspector in October 2008. She has since taken up the post of GPvP (Good Pharmacovigilance Practice) Operations Manager and is cross-training as a Pharmacovigilance Inspector. Prior to joining the MHRA, Mandeep worked for the pharmaceutical industry, the MHRA and the NHS. Mandeep has a BSc (Hons) in Pharmacology from King’s College London and is studying for an MSc in Public Health. Mandeep is also the current chair of the PIC/S GCP & GPvP Working Group.
Help us with the key topics you would like to hear about
The Medicines and Healthcare products Regulatory Agency (MHRA) has embarked on a recent initiative to evaluate the feasibility of conducting stand-alone inspections of pharmacovigilance contract service providers. In July 2003 MHRA introduced a statutory pharmacovigilance inspection programme of marketing authorisation …
Related content and links
About the MHRA Inspectorate Blog
This blog shares the work of the Medicines and Healthcare products Regulatory Agency (MHRA) Inspectorate, by inspectors and those the Inspectorate works with.
MHRA Inspectorate & Process Licensing Organogram
Other MHRA Blogs
Comments and moderation
- Inspectors grounded - a year of innovation
- Pharmacovigilance inspection metrics April 2019 to March 2020
- Guidance on pharmacovigilance requirements for UK authorised products from 1 January 2021
- Reference Safety Information (RSI) for Clinical Trials- Part III
- Pharmacovigilance requirements for UK authorised products - 13 January 2021